AI Sales OS for Diagnostics

The AI sales engine for global diagnostics.

Eunobio is a data-driven sales company. We embed AI into every commercial decision — product selection, account targeting, sales execution, and payer evidence — so diagnostics products win in the US market.

Product Intelligence · GeoAccount · Account Ranking · Sales Copilot · Payer Evidence

AI Sales Loop learns every deal Product Intel Geo Account Account Ranking Sales Copilot Payer Evidence

Why Eunobio

We own the full diagnostics commercialization loop — not a distributor that happens to use software.

Most foreign diagnostics products don't fail for lack of science. They fail because of a product–market–payer–customer mismatch that exists before launch even begins. Eunobio rebuilds commercialization around data: every decision is scored, every closed deal feeds the model, and the engine gets smarter over time.

01

Data

Market, accounts, products, reimbursement, and field execution — aggregated into one source.

02

Knowledge Graph

Product–account–physician–reimbursement relationships modeled as a network.

03

Scoring

RAEV scoring quantifies risk and return for every commercial decision.

04

Action

Next-best-action recommendations drive CRM updates and meeting agendas directly.

05

Learning

Closed-deal outcomes feed back into scoring, continuously improving accuracy.

The Platform

Five AI engines drive every commercial decision.

Each engine scores one decision. Together they form the complete sales loop — the daily command center that tells the team exactly what to do next.

Product Intelligence

Identifies true product-market fit gaps from customer-need data, guiding product design and portfolio optimization.

Product Fit Score

GeoAccount

Builds a nationwide account map by geography, health-system affiliation, and testing volume.

Account Opportunity Score

Account Ranking

RAEV (Risk-Adjusted Expected Value) ranks accounts so sales resources focus on the highest-return opportunities.

RAEV Priority

Sales Copilot

Delivers next-best-action guidance, talk tracks, and competitive data to reps — embedded directly in the CRM.

Best Next Action

Payer Evidence

Synthesizes Medicare/Medicaid and commercial payer policies, CPT codes, and reimbursement pathways to reduce access risk.

Reimbursement Viability

The Feedback Loop

Field sales data flows back into the knowledge graph and scoring model — every sale makes the next decision more accurate.

How it works →

The Portfolio

Diagnostics products built — and commercialized — around real customer need.

From point-of-care urinalysis to oncology NGS, every product is matched to assay coverage, customer demand, and a clear reimbursement pathway.

Urinalysis

MU500™ Platform

Cloud-connected urinalysis analyzer with AI image processing, open HL7/FHIR, and a razor-blade reagent model.

<60sResult time
HL7 / FHIROpen integration
Pathogen ID + AMR

NexFlex Panel

AI-designed modular panel — single panel, single internal control, 99-mix library covering pathogen ID and antimicrobial resistance.

99-mixModular library
100%Core need coverage
Neurology

Alzheimer's Blood Test

Whole-blood electrochemiluminescence analyzer — central-lab-grade accuracy at the clinical frontline, no centrifugation.

12 minWhole-blood TAT
CV <3%Precision
Oncology NGS

NGS + Payer Evidence

An NGS panel where the moat is the reimbursement pathway — PLA codes, LCD dossiers, and payer engagement, all pipelined by AI.

12–18 moCoverage pathway
4-trackPayer strategy
View all products →

Get in touch

Questions, partnerships, or a coffee. We're open.

Whether you're a diagnostics manufacturer looking to enter the US, an investor, or a lab partner — we'd like to hear from you.